Thursday, November 20th, 2008
November 11th, 2008 – The British Government has released data confirming that, like the United States, users of Champix, the European version of the stop-smoking drug known as Chantix in the United States, have been reporting a number of adverse reactions associated with the drug, including suicides and suicidal thoughts.
Chantix and Champix, which are both manufactured by Pfizer, Inc., contain the pharmaceutical ingredient varenicline tartrate, which blocks brain receptors that are normally stimulated by nicotine. The drug is designed to lessen the pleasure effects of nicotine and help users quit smoking.
In the United States, Chantix has been associated with a number of serious and potentially life-threatening side effects, including an increased risk of suicide, suicide attempts and unusual behavior. A number of users have also report developing new-onset diabetes after taking the drug and suffering seizures and blackouts, which could result in serious accidents or injury.
Tags: chantix, Chantix News, chantix suicides
Posted in Chantix News, Legal News | Comments Off
Saturday, November 15th, 2008
According to the Wall Steet Journal, The FDA said it might upgrade warnings on Pifzer’s Chantrx drug due to recent road-traffic accidents and seizures involving people on Chantix.
According to the Journal article:
The Institute for Safe Medication Practices said 1,001 serious incidents involving Chantix users were reported in the first quarter of this year, based on its analysis of government safety data. That is more than the total number of serious incidents for the top 10 most-prescribed brand-name drugs combined.
Chantix already has been linked to serious psychiatric side effects such as depression and suicidal behavior. In 2007 Pfizer strengthened the warning label. The company has said that nicotine withdrawal itself “can cause changes in behavior, such as irritability and depressed mood.”
This Spring, the FDA issued a warning guide for doctors perscribing Chantix.
Chantix, which had $883 million in total 2007 sales, has experienced a steep decline. Its third-quarter sales in the U.S. fell 49% from last year’s third quarter, dropping to $96 million from $186 million. This summer, Pfizer took out full-page ads in major newspapers defending the drug and noting the severe risks to health from smoking.
Tags: chantix, chantix seizures, chantix suicides, chantrix, pfizer
Posted in Chantix News, Legal News | Comments Off